Stock Scorecard
Stock Summary for CryoPort Inc (CYRX) - $17.48 as of 4/15/2024 3:26:10 PM EST
Total Score
8 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CYRX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CYRX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CYRX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for CYRX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for CYRX
Financial Details for CYRX
Company Overview |
|
|---|---|
| Ticker | CYRX |
| Company Name | CryoPort Inc |
| Country | USA |
| Description | Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/2/2024 |
Stock Price History |
|
| Last Day Price | 17.48 |
| Last Day Price Updated | 4/15/2024 3:26:10 PM EST |
| Last Day Volume | 0 |
| Average Daily Volume | 538,957 |
| 52-Week High | 24.17 |
| 52-Week Low | 9.00 |
| Last Price to 52 Week Low | 94.22% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 99.80 |
| Sector PE | 62.54 |
| 5-Year Average PE | -36.38 |
| Free Cash Flow Ratio | 1.88 |
| Industry Free Cash Flow Ratio | 12.80 |
| Sector Free Cash Flow Ratio | 32.12 |
| Current Ratio Most Recent Quarter | 11.73 |
| Total Cash Per Share | 9.29 |
| Book Value Per Share Most Recent Quarter | 9.45 |
| Price to Book Ratio | 1.86 |
| Industry Price to Book Ratio | 5.60 |
| Sector Price to Book Ratio | 22.02 |
| Price to Sales Ratio Twelve Trailing Months | 3.68 |
| Industry Price to Sales Ratio Twelve Trailing Months | 14.20 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.31 |
Share Statistics |
|
| Total Shares Outstanding | 49,164,500 |
| Market Capitalization | 859,395,460 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -166.75% |
| Reported EPS 12 Trailing Months | -2.21 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -2.20 |
| Net Income Twelve Trailing Months | -99,587,000 |
| Net Income Past Year | -99,587,000 |
| Net Income Prior Year | -37,333,000 |
| Quarterly Revenue Growth YOY | -5.10% |
| 5-Year Revenue Growth | 64.06% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 456,755,000 |
| Total Cash Past Year | 456,755,000 |
| Total Cash Prior Year | 522,614,000 |
| Net Cash Position Most Recent Quarter | 83,694,000 |
| Net Cash Position Past Year | 83,694,000 |
| Long Term Debt Past Year | 373,061,000 |
| Long Term Debt Prior Year | 398,279,000 |
| Total Debt Most Recent Quarter | 373,061,000 |
| Equity to Debt Ratio Past Year | 0.57 |
| Equity to Debt Ratio Most Recent Quarter | 0.57 |
| Total Stockholder Equity Past Year | 489,023,000 |
| Total Stockholder Equity Prior Year | 560,518,000 |
| Total Stockholder Equity Most Recent Quarter | 489,023,000 |
Options |
|
| Put/Call Ratio | 0.02 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.48 |
| MACD Signal | 0.53 |
| 20-Day Bollinger Lower Band | 13.90 |
| 20-Day Bollinger Middle Band | 16.15 |
| 20-Day Bollinger Upper Band | 18.39 |
| Beta | 1.59 |
| RSI | 51.12 |
| 50-Day SMA | 15.60 |
| 200-Day SMA | 35.92 |
System |
|
| Modified | 4/15/2024 10:12:22 PM EST |